In 2023, we attended the 18th International Congress of Immunology, hosted by the International Union of Immunological Societies, in Cape Town, South Africa, and recorded daily episodes discussing highlights of the conference. Here is the third of five special episodes from the meeting, in which Brenda and Jason discuss research on T cell exhaustion in chronic infections and sex differences in immune responses.
![The Immunology Podcast cover image](https://images.weserv.nl/?url=https%3A%2F%2Fimmunologypodcast.com%2Fwp-content%2Fuploads%2F2021%2F03%2FIP-logo-TM-1400x1400-1.jpg&w=320&h=320&output=jpg)
The Immunology Podcast
IUIS 2023: Day 3
Dec 1, 2023
Discover the intriguing research on T-cell exhaustion and its role in chronic infections and cancer therapy. The discussion highlights gender differences in immune responses, revealing women often have stronger immunity but face autoimmunity challenges. Explore how gut health impacts cancer outcomes and the potential benefits of beta blockers. The podcast also dives into new findings about LYVE1 positive macrophages and their importance for vascular health, alongside insights into genetic mutations and their influence on immune conditions.
24:47
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Research on T cell exhaustion indicates that targeting stem-like CD8 T-cells can enhance immunotherapy effectiveness in chronic infections and cancer.
- Investigations into sex differences in immune responses reveal that while females have stronger immunity, they also experience higher autoimmune disorder rates.
Deep dives
Understanding T-Cell Exhaustion
A significant theme discussed is T-cell exhaustion, particularly in the context of chronic viral infections and cancer treatment. Rafi Ahmed from Emory University presented pioneering work in this area, highlighting the role of TCF1 positive, PD-1 expressing stem-like CD8 T-cells during chronic infections. These cells play a crucial role in maintaining the effector T-cell population over time, and targeting these cells through combined therapies with anti-PD and IL-2 can enhance their effectiveness. This dual approach not only addresses inhibition but also promotes sustained proliferation of T-cells, indicating promising strategies for immunotherapy.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.